The new multidisciplinary open access journal for scientifically rigorous research in the life and medical sciences

Re:GEN Open combines the dynamic, global media presence of Genetic Engineering & Biotechnology News (GEN) with the scientific peer-reviewed publishing expertise of Mary Ann Liebert, Inc. to deliver an unprecedented publishing experience: best-in-class author services, rapid and fair peer review, and international exposure for your work.

basic biomedical research
translational biomedical research
Synthetic and Systems Biology
regenerative medicine
cancer research
drug development
cell and gene therapy
infectious disease

Announcements

18 Apr 2022

Most-Read Article:
CRISPR Knock-in Designer: Automatic Oligonucleotide Design Software to Introduce Point Mutations by Gene Editing Methods
Read Article

20 Jan 2022

Re:GEN Open's first continuous volume is available on topics such as CRISPR, CAR-T cells, antiretroviral therapy, cancer research, and more.
Read Full Volume

The only choice for your next manuscript

The things that matter to you are the things that matter to us: speed, credibility, authority, visibility, and discoverability.

Re:GEN Open is the home for your next manuscript.

Submit Your Manuscript
  • Re:GEN Open combines the dynamic, global media presence of Genetic Engineering & Biotechnology News (GEN) with the scientific peer-reviewed publishing expertise of Mary Ann Liebert, Inc., publishers to deliver an unprecedented publishing experience
  • Fast publishing time with current submission to first decision less than 3 weeks
  • Broad audience for your article and international exposure across the leading media platforms in the industry

Latest Articles

Jun 01, 2022
Identification of NUDT15*3 Variant in the Bangladeshi Population using Allele-Specific PCR
Drishty Badhon Sarker, Md. Mahmudul Hasan Akash, Abu Ashfaqur Sajib, and Sharif Akhteruzzaman
Apr 28, 2022
3D Structure Elucidation and Appraisal of Mode of Action of a Bacteriocin BaCf3 with Anticancer Potential Produced by Marine Bacillus amyloliquefaciens BTSS3
Bindiya Ellathuparambil Saidumohamed, Tina Kollannoor Johny, Anju Thoppil Raveendran, Unnikrishanan Babukuttan Sheela, Maya Sreeranganathan, Raghul Subin Sasidharan, and Sarita Ganapathy Bhat
Apr 21, 2022
Cancer Incidence, Risk Factors, and Survival in a 31 Years-Old Brazilian HIV Cohort
Beatriz R. Pellegrina Soares, Gabriela Prates, Mariana A. Monteiro, Rosa M. N. Marcusso, Fernanda de Toledo Gonçalves, Najara A. de Lima Nascimento, Thales Poli, Ana Paula R. Veiga, Mauricio D. Ferreira, Marcello M. C. Magri, Luiz A. M. Fonseca, Alberto J. S. Duarte, Jorge Casseb, and the ADEE3002 Group
Mar 03, 2022
Development of an Assay to Distinguish Between Genotypes of the Leucyl-Cystinyl Aminopeptidase Gene
Nayan J. Sarma, Shannon R. Dalton, and Saji Vijayan
Feb 14, 2022
Screening for Acute HIV Infection in Fortaleza, Brazil: What Would Be the Best Strategy?
Luciana Pinto Bandeira, Natália Gimeniz Galvão, Lucas Pinho Alves, Ana Séfora Marques Magalhães, Richeyla Kelly de Assis Custódio, Luciana Maria de Barros Carlos, Elaine Monteiro Matsuda, Luís Fernando de Macedo Brígido, Danielle Malta Lima, and Jeová Keny Baima Colares
Jan 18, 2022
Potential of Favipiravir and Minocycline Combination Therapy for COVID-19
Kazuhiro Itoh, Hiroshi Tsutani, and Hiromichi Iwasaki